ABOUT US | MedXCell is a Swiss specialist healthcare group with clinical-stage projects. It is dedicated to transforming healthcare through the development and production of affordable and accessible new therapies utilizing the unique healing powers of living cells.
MedXCell is devoted to the development and the manufacturing of innovative off-the-shelf cellular therapies offering state-of-the-art, cost-effective and safe solutions for a wide range of patient needs. The company enjoys a close relationship with academic research and has two distinct entities, MedXCell Science and MedXCell NKar, representing its two main technologies.
“MedXCell is the challenge of a lifetime, being able to create ultra efficient and accessible treatments isn’t the norm yet. But our goal is to reverse that paradigm.”
Laurent Zbinden, CEO